SUNPHARMA Sun Pharmaceutical Industries Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · Nifty 50 Weight: 1.66%Live setups screens SUNPHARMA is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about SUNPHARMA
In the last completed session, Sun Pharmaceutical Industries Ltd. closed -0.82% with futures open interest moving -0.8%. That combination — price falling while OI shrinks — is classified as Long Unwinding. Existing longs are exiting rather than new shorts being added; the move down lacks the conviction of fresh selling. The stock's option PCR sits at 0.43, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,920 sits 1.1% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Sun Pharmaceutical Industries Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Sun Pharmaceutical Industries Ltd. points to a softer setup at the next open.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
| Date | Side | Price | Value (Cr) | Counterparty |
|---|---|---|---|---|
| 2026-06-24 | BUY | ₹ 1,868.00 | 28.85 | THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794 |
| 2026-06-24 | SELL | ₹ 1,868.00 | 28.85 | THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828 |
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-09-29 · spot 1,899 · EOD 2026-09-04
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 37%
Δ 0.78
θ -1.4
ν 1
|
1780 | |
| 1800 | ||
|
IV 17%
Δ 0.86
θ -0.7
ν 1
|
1820 |
IV 16%
Δ -0.13
θ -0.3
ν 1
|
|
IV 13%
Δ 0.86
θ -0.6
ν 1
|
1840 |
IV 16%
Δ -0.18
θ -0.4
ν 1
|
|
IV 13%
Δ 0.78
θ -0.7
ν 1
|
1860 S |
IV 15%
Δ -0.26
θ -0.4
ν 2
|
|
IV 13%
Δ 0.68
θ -0.7
ν 2
|
1880 |
IV 15%
Δ -0.35
θ -0.4
ν 2
|
|
IV 13%
Δ 0.55
θ -0.7
ν 2
|
1900 |
IV 15%
Δ -0.45
θ -0.4
ν 2
|
|
IV 13%
Δ 0.43
θ -0.7
ν 2
|
1920 MP |
IV 15%
Δ -0.56
θ -0.4
ν 2
|
|
IV 13%
Δ 0.31
θ -0.6
ν 2
|
1940 R |
IV 15%
Δ -0.66
θ -0.3
ν 2
|
|
IV 14%
Δ 0.22
θ -0.5
ν 1
|
1960 |
IV 16%
Δ -0.74
θ -0.3
ν 2
|
|
IV 14%
Δ 0.16
θ -0.4
ν 1
|
1980 |
IV 14%
Δ -0.86
θ -0.0
ν 1
|
| 2000 |
IV 14%
Δ -0.91
θ +0.1
ν 1
|
|
| 2020 |
IV 18%
Δ -0.90
θ +0.0
ν 1
|
Chain Interpretation
Strategy Builder multi-leg payoff for SUNPHARMA options · 2026-09-29 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
SUNPHARMA — frequently asked questions
What is the Sun Pharmaceutical Industries Ltd. share price today?
SUNPHARMA is trading at ₹1,899.00 (-0.89% vs previous close), per the latest update on this page.
What is the P/E ratio of Sun Pharmaceutical Industries Ltd.?
SUNPHARMA (Sun Pharmaceutical Industries Ltd.) has a trailing twelve-month P/E ratio of 37.7.
What is the market cap of Sun Pharmaceutical Industries Ltd.?
SUNPHARMA has a market capitalisation of approximately ₹455,634 crore.
Is SUNPHARMA near its 52-week high?
SUNPHARMA is trading -7.2% from its 52-week high of ₹2,046.90 as of 2026-09-04.
What is the RSI of SUNPHARMA?
The 14-day RSI of SUNPHARMA is 44.6, which is considered neutral.
Is SUNPHARMA above its 200-day moving average?
SUNPHARMA is trading above its 200-DMA of ₹1,803.79 (+5.3% away).
What is the F&O buildup in SUNPHARMA?
The latest end-of-day derivatives data classifies SUNPHARMA as Long Unwinding (bias: bearish), based on the day's combined price and open-interest change.
What is the max pain and PCR for SUNPHARMA options?
SUNPHARMA's option-chain max pain strike is ₹1,920 and its put-call ratio (OI) is 0.43, from the latest end-of-day option chain.
Are FIIs or big investors buying SUNPHARMA?
Strota tracks every bulk and block deal in SUNPHARMA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.